Pharma Times – Regulatory concerns about adaptive trials are easing, says Perceptive
By Peter Mansell Growing implementation of adaptive clinical trials following the publication of draft guidance on adaptive designs by the US Food and Drug Administration in February 2010 is helping to ease regulatory concerns within industry about the approach, says eClinical solutions specialist Perceptive Informatics…read more


